evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/geneAliases/6,gene/geneAliases/7,gene/geneAliases/8,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract
13855,GENE_BACKGROUND,,"The breast cancer 1, early onset (BRCA1) gene, which functions as a tumor suppressor, is a multifunctional ubiquitin E3 ligase. It has many cellular functions including transcription, protein ubiquitination, cell cycle regulation and DNA damage response, with a particularly important role in homologous recombination, a DNA double strand break repair pathway. BRCA1 was the first breast and ovarian cancer susceptibility gene identified and cloned; inherited mutations in this gene lead to an increased lifetime risk of developing these cancers. BRCA1 mutations confer a 70-80% lifetime risk of breast cancer, a 50% lifetime risk of ovarian cancer and an increased risk of prostate cancer in patients with Ashkenazi Jewish BRCA1 founder mutations (PMID: 22193408). If one copy of BRCA1 is mutated in the germline, the result is hereditary breast and ovarian cancer (HBOC) syndrome, an autosomal dominant disease (PMID: 22193408). BRCA1 was also recently identified as a definitive Fanconi anemia susceptibility gene in FANCS, a rare Fanconi anemia subtype that results from biallelic mutations in the gene (PMID: 25472942). BRCA1 has three major domains: the N-terminal RING (Really Interesting New Gene) domain (exons 2-7) that contains an active zinc finger motif, exons 11-13, and the BRCT (BRCA1 C-terminal) domain. Many clinically significant mutations of BRCA1 are located in the zinc finger motif of the RING domain, which is important for many protein-protein interactions (PMID: 11573085). Exons 11-13 contain binding sites for proteins including RB, c-MYC, RAD50, and RAD51 (reviewed in PMID: 10918303). Despite the fact that exons 11-13 contain many clinically significant BRCA1 mutations, little is known about the structure or function of this region when compared to the RING or BRCT domains (PMID: 18273555). The BRCT domain is essential to the tumor suppressor function of the BRCA1 protein via its crucial role in transcriptional regulation and DNA repair (PMID: 11877378, 11118345). p53 mutations in breast tumors are seen almost exclusively with BRCA1 and BRCA2 mutations, suggesting that p53 loss of function may be a necessary step in the tumorigenesis of BRCA-associated carcinomas (PMID: 14672397).",,2017-04-26,,672,BRCA1,"BRCA1, DNA repair associated",False,ENST00000357654,NM_007294.3,RNF53,IRIS,BRCAI,PNCA4,PSCP,BROVCA1,BRCC1,FANCS,PPP1R53,True,18273555,Community benchmarks for virtual screening.,Journal of computer-aided molecular design,2018-03-01T20:08:00,22,2001-03-04,193-9,Irwin JJ,doi: 10.1007/s10822-008-9189-4,,2001-03-04,,11118345,The BRCT regions of tumor suppressor BRCA1 and of XRCC1 show DNA end binding activity with a multimerizing feature.,Biochemical and biophysical research communications,2017-12-20T20:00:00,279,2,678-84,Yamane K et al,,,0001-12-20,,14672397,p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.,Breast cancer research and treatment,2018-11-01T20:03:00,82,True,2001-01-09,Sensi E et al,,,0001-11-01,,11877378,Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.,Genes &amp; development,2018-03-01T20:02:00,16,5,583-93,Joo WS et al,,,0001-03-01,,11573085,Structure of a BRCA1-BARD1 heterodimeric RING-RING complex.,Nature structural biology,2018-10-01T20:01:00,8,10,833-7,Brzovic PS et al,,,0001-10-01,,22193408,BRCA1 and BRCA2: different roles in a common pathway of genome protection.,Nature reviews. Cancer,2017-12-23T20:11:00,12,True,68-78,Roy R et al,doi: 10.1038/nrc3181,,0001-12-23,,25472942,Biallelic mutations in BRCA1 cause a new Fanconi anemia subtype.,Cancer discovery,2018-02-01T20:15:00,5,2,135-42,Sawyer SL et al,doi: 10.1158/2159-8290.CD-14-1156,,0001-02-01,,10918303,Roles of BRCA1 and its interacting proteins.,"BioEssays : news and reviews in molecular, cellular and developmental biology",2018-08-01T20:00:00,22,8,728-37,Deng CX et al,,,0001-08-01,
13854,GENE_SUMMARY,,BRCA1 is a tumor suppressor involved in the DNA damage response and can be mutated in various cancer types.,,2017-08-03,,672,BRCA1,"BRCA1, DNA repair associated",False,ENST00000357654,NM_007294.3,RNF53,IRIS,BRCAI,PNCA4,PSCP,BROVCA1,BRCC1,FANCS,PPP1R53,True,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
